Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06594887 · ClinicalTrials.gov registry record · NA

Rectal Spacers Use in Prostate Cancer Radiation Therapy

A NA study of Prostate Cancer, sponsored by Princeton ProCure management.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT06594887: Recruiting NA study of Prostate Cancer, sponsored by Princeton ProCure management.

NCT06594887 is a NA study of Prostate Cancer that is actively recruiting participants, run by Princeton ProCure management. The registered enrollment target is 50 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06594887, a NA study of Prostate Cancer, is actively recruiting participants, sponsored by Princeton ProCure management.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

This prospective, 2-arm clinical trial aims to evaluate the use of rectal spacers in patients with localized prostate cancer scheduled for Proton Beam Therapy (PBT). Up to 50 subjects will be enrolled in this study. Study visits will include screening, spacer placement, treatment planning, end-of-treatment assessment, and follow-up visits at 1, 3, and 6 months.

Conditions Studied

Interventions

  • DEVICE SpaceOAR Vue
  • DEVICE BioProtect Balloon Implant System

Study Locations (1)

New Jersey

  • Procure Proton Therapy Center - Somerset

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2024-09-06
Est. Completion 2025-12
Phase NA

Sponsor

Princeton ProCure management

1 total trials

What the Registry Record Tells You About NCT06594887

The ClinicalTrials.gov registry entry for NCT06594887 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (92% lower). The listed sponsor is Princeton ProCure management, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 2 interventions - of which SpaceOAR Vue is the first listed.

NCT06594887 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT06594887 about?

NCT06594887 is a clinical study titled "Rectal Spacers Use in Prostate Cancer Radiation Therapy". This prospective, 2-arm clinical trial aims to evaluate the use of rectal spacers in patients with localized prostate cancer scheduled for Proton Beam Therapy (PBT). Up to 50 subjects will be enrolled in this study. Study visits will include screening, spacer placement, treatment planning, end-of-t...

What is the current status of trial NCT06594887?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2024-09-06. Estimated completion is 2025-12.

What conditions does trial NCT06594887 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT06594887?

The interventions under investigation include: SpaceOAR Vue (DEVICE), BioProtect Balloon Implant System (DEVICE).

Who is sponsoring clinical trial NCT06594887?

This trial is sponsored by Princeton ProCure management, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06594887 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.